Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
To assess the safety and tolerability of multiple subcutaneous doses of AMG 181 in healthy
subjects, in subjects with active ulcerative colitis, and in subjects with active Crohn's
disease.